Get Started

VOGX

NASD Vogenx, Inc.
Nov 6, 2026 · 2:26 PM ET DELAYED Market Open

$17.56 ↓ -0.68 (-3.70%) Trading Down from the previous close of $18.23, $1.35 below the day’s high of $18.90

YTD change
+35.04%
vs 20-day SMA
-3.69%
vs 200-day SMA
N/A

Price ranges

Previous day
$17.70 $19.87
open $19.23 close $18.23
-$1.00 (-5.20%)
Today
$17.14 $18.90
open $18.19 now $17.56
-$0.64 (-3.49%)
Past week
$17.70 $21.95
from $19.92 now $17.56
-$2.37 (-11.87%)
Past month
$14.25 $22.24
from $17.49 now $17.56
+$0.07 (+0.37%)
This year
$12.95 $38.41
from $13.00 now $17.56
+$4.56 (+35.04%)

Price & Performance

+5.23 (+40.23%) / 6M

$11.31$19.48$27.65$35.82Aug 12Sep 24Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 54.3% away from all-time highs of $38.41
  • VOGX is up 35% since the beginning of the year
  • VOGX is up 35% over the past 12 months
  • VOGX is up 0% over the past 1 month
  • 0% of all VOGX investors are betting against VOGX

VOGX reads poor: the 12-month move is +40.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.085
Earnings momentum +5.6% Quarterly EPS growth
Quarterly change +5.6%

Valuation

P/E ratio N/A
Enterprise value $271.5M

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$193.0K
Debt$868.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $260.8M

Vogenx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery and development of treatments for serious metabolic and gastrointestinal diseases. The company was founded by James Green, William Wilkison, and Steven Delmar on February 5, 2021 and is headquartered in Raleigh, NC.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $902.90 -2.98%
IQV IQVIA Holdings Inc $264.88 +0.41%
ICLR ICON Plc $201.65 -0.72%
CRL Charles River Laboratories International, Inc. $313.02 -4.07%
IT Gartner, Inc. $198.07 -4.40%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.